Tocilizumab for juvenile idiopathic arthritis: a single-center case series

BACKGROUND: Juvenile idiopathic arthritis (JIA) is the commonest chronic rheumatic disease among children. When not treated effectively, JIA can lead to functional disability, due to joint damage, along with long-term morbidities. OBJECTIVES: To describe the use of tocilizumab therapy for 11 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazılıtaş, Fatma, Özdel, Semanur, Şimşek, Doğan, Aydoğ, Özlem, Çakıcı, Evrim Kargın, Can, Gökçe Gür, Güngör, Tülin, Bülbül, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754278/
https://www.ncbi.nlm.nih.gov/pubmed/32159638
http://dx.doi.org/10.1590/1516-3180.2018.0489220719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754278/
https://www.ncbi.nlm.nih.gov/pubmed/32159638
http://dx.doi.org/10.1590/1516-3180.2018.0489220719

Ejemplares similares